Skip to main content
. 2016 Dec 20;83(5):1082–1096. doi: 10.1111/bcp.13186

Figure 4.

Figure 4

Simulated average plasma concentration time profile for a single 15 mg oral dose of S‐warfarin with and without 300 mg once daily canagliflozin in healthy subjects compared with observed plasma concentration time profile for a single 30 mg oral dose of warfarin (which contained 50% S‐warfarin) with and without 300 mg once daily canagliflozin in healthy subjects